The DUSP23 Knockout A-549 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population in which the DUSP23 gene has been disrupted in the A-549 human lung adenocarcinoma cell line. This polyclonal population offers a heterogeneous mix of edited alleles, providing a robust loss-of-function model for studying DUSP23 biology.
The A-549 cell line, originating from human lung carcinoma, is a well-characterized model of pulmonary adenocarcinoma. These cells display epithelial morphology and are commonly employed in studies of lung cancer biology, including tumorigenesis, metastasis, and therapeutic response. As an adherent cell line, A-549 cells maintain key oncogenic signaling pathways, making them particularly suitable for examining the roles of phosphatases like DUSP23 in cancer cell behavior.
DUSP23 encodes a dual-specificity phosphatase that selectively dephosphorylates and inactivates JNK and p38 MAP kinases, thereby negatively regulating MAPK signaling cascades. The protein is activated by cellular stress, growth factor stimuli, and integrin signaling, and it directly interacts with focal adhesion components including paxillin and FAK. Through its association with paxillin, DUSP23 localizes to focal adhesions, where it modulates the phosphorylation status of downstream targets such as c-Jun and ATF2, ultimately controlling focal adhesion turnover and cell migration.
In the A-549 lung adenocarcinoma background, DUSP23 disruption is anticipated to perturb the delicate balance of MAPK signaling. Given the critical roles of JNK and p38 in cellular processes such as proliferation, apoptosis, and migration, the loss of DUSP23-mediated dephosphorylation may lead to sustained kinase activation, altered focal adhesion assembly, and enhanced cell motility. This polyclonal knockout model thus provides a physiologically relevant platform for investigating how DUSP23 influences oncogenic signaling and metastatic behavior in non-small cell lung cancer.
Researchers can employ this DUSP23 polyclonal knockout model in a variety of assays to elucidate its function. Typical applications include Western blotting or phospho-signaling analysis to assess JNK and p38 activity, RT-qPCR to monitor gene expression changes, and cell migration assays such as wound healing or transwell invasion to evaluate metastatic potential. Immunofluorescence staining for focal adhesion markers like paxillin and co-immunoprecipitation experiments further enable mechanistic dissection of DUSP23 interactions. This knockout cell population is an essential tool for advancing our understanding of phosphatase-mediated regulation in lung adenocarcinoma. For further details, please contact Ascent Research.
